Structural Formula (Image 01)
Katerzia Suspension
Product Images NDC 52652-5001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Katerzia (NDC 52652-5001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Image 02)
This is a graphical representation of the event rate over time. The numbers on the y-axis represent the percentage of individuals experiencing the event at each time point on the x-axis. The P-value and Hazard ratio are also provided, along with the corresponding 95% confidence interval. The chart includes several lines each representing a population with different characteristics. There is also a table indicating the number of individuals at risk at different time points.*
Figure 2 (Image 03)
This table provides data on a study that compares the effectiveness of Amlodipine versus Placebo on patients with hypertension who underwent different treatments, including stent placement. The study included 1318 patients with various demographic and clinical characteristics, such as gender, baseline sitting SBP, baseline vessel disease, and baseline vessels with stenosis. The hazard ratio with 95% confidence interval is presented in the last row, indicating that Amlodipine had a beneficial effect over Placebo.*
Principal Display Panel (Bottle Label)
This is a medication with the National Drug Code (NDC) 52652-5001-1, named Katerzia. It is an oral suspension containing 1 mg of amlodipine benzoate per 1 mL. The usual dose is not available, and the user should refer to the prescribing information. The medication must be shaken before use, and it needs to be refrigerated at 2°-8°C (36° - 46°F) and protected from light. The manufacturer is Aaurity Pharmaceuticals, Inc. The text also includes some cautionary notes such as keeping it out of children's reach and avoiding excessive heat and freezing.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
